# The Effectiveness of the Android Application as a Pharmaceutical Education Tool in Hypertensive Patients

Study · id `cardio:ct-nct05728723` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05728723](<https://clinicaltrials.gov/study/NCT05728723>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05728723

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT05728723. Non-randomized; double masking; primary purpose prevention. Start 2023-03-16 (actual); primary completion 2023-06-16 (actual). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; double masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT05728723, source copy `cardio:ctgov-nct05728723-2023-08-15`, retrieved 2026-10-26)
- Started: 2023-03-16 (actual) (ClinicalTrials.gov record NCT05728723, source copy `cardio:ctgov-nct05728723-2023-08-15`, retrieved 2026-10-26)
- Primary completion: 2023-06-16 (actual) (ClinicalTrials.gov record NCT05728723, source copy `cardio:ctgov-nct05728723-2023-08-15`, retrieved 2026-10-26)
- Completion: 2023-06-16 (actual) (ClinicalTrials.gov record NCT05728723, source copy `cardio:ctgov-nct05728723-2023-08-15`, retrieved 2026-10-26)
- Countries: Indonesia (ClinicalTrials.gov record NCT05728723, source copy `cardio:ctgov-nct05728723-2023-08-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05728723-2023-08-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Effectiveness of the Android Application as a Pharmaceutical Education Tool in Hypertensive Patients
- Condition: Hypertension
- Intervention (Device): Android Application
- Intervention (Behavioral): Pharmacy education
- Lead sponsor: Universitas Padjadjaran
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)

## Provenance

Content hash: 7508e07f4b0fc57c44efd8ebaa31e19f7c210fd9bfd672e11905315f8d142088
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
